Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City
Authors:
Open Access
- 19 July 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0181702
Abstract
Black men who have sex with men (MSM), and Transwomen (TW) shoulder disproportionate burden of HIV. However, they are unrepresented in HIV vaccine trials. We investigated the perceptions of that factors associated with HIV vaccine trials participation among Black MSM and TW in New York. Self-administered online questionnaires were administered to 18–29 years of NYC residents who identified as Black MSM and TW, assessing demographics, awareness and willingness to participate in HIV vaccine trials, barriers and facilitators associated with willingness, and sexual behaviors. Frequency summation was performed to determine barriers and facilitators, and logistic regression analysis was performed to determine factors association with expressed willingness. Black MSM and TW who reported engaging in risk behaviors had a 61% lower likelihood of participating in HIV vaccine trials when compared to those who did not report engaging in any risk behavior. Facilitators associated with trial participation were: cash compensation, confidentiality regarding participation, public transportation vouchers, gift cards, and food or grocery vouchers as potential facilitators for trial participation. Conversely, fear of side effects from the vaccine, concerns about testing positive on routine HIV testing due to an HIV vaccine, limited knowledge of research trials, and fear of being judged as HIV-positive were perceived as barriers. These findings provided insights into the considerations and perceptions of Black MSM and TW towards HIV vaccine trials. However, further studies are needed to delineate the complex mechanisms underlying the decision-making process and establish approaches to increase study participation in this population.Keywords
Funding Information
- the National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service Grant (UM1 AI068614)
This publication has 25 references indexed in Scilit:
- HIV Related High Risk Behaviors and Willingness to Participate in HIV Vaccine Trials among China MSM by Computer Assisted Self-Interviewing SurveyBioMed Research International, 2013
- Estimating the Population Size of Men Who Have Sex with Men in the United States to Obtain HIV and Syphilis Rates§The Open AIDS Journal, 2012
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Barriers of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studiesVaccine, 2011
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Preventive HIV Vaccine Acceptability and Behavioral Risk Compensation among a Random Sample of High‐Risk Adults in Los Angeles (LA VOICES)Health Services Research, 2009
- Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trialVaccine, 2008
- Novel Approach for Differential Diagnosis of HIV Infections in the Face of Vaccine-Generated AntibodiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. CommunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Willingness to participate in HIV-1 vaccine trials among young Thai menSexually Transmitted Infections, 2000